TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3%
Fri, 1 Nov

TORRENT PHARMA has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:

TORRENT PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-18*
3
Jun-19*
3
Sep-19*
QoQ ChangeYoY Change
Net SalesRs m18,94020,22020,050-0.8%5.9%
Other incomeRs m10020034070.0%240.0%
TurnoverRs m19,04020,42020,390-0.1%7.1%
ExpensesRs m14,21014,81014,640-1.1%3.0%
Gross profitRs m4,7305,4105,4100.0%14.4%
DepreciationRs m1,5201,6001,6301.9%7.2%
InterestRs m1,2601,2201,160-4.9%-7.9%
Profit before taxRs m2,0502,7902,9606.1%44.4%
TaxRs m260630520-17.5%100.0%
Profit after taxRs m1,7902,1602,44013.0%36.3%
Gross profit margin%25.026.827.0
Effective tax rate%12.722.617.6
Net profit margin%9.410.612.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 5.9% on a year-on-year (YoY) basis. The expenses were up by 3.0% YoY during the same period.
  • The company's operating profit increased by 14.4% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.0% in 2QFY20 as against 25.0% in 2QFY19.
  • Depreciation charges increased by 7.2% and finance costs declined by 7.9% YoY, respectively.
  • Other income increased by 240.0% YoY during the quarter.
  • Net profit for the quarter increased by 36.3% YoY. Net profit margins during the quarter increased from 9.4% in 2QFY19 to 12.0% in 2QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 0.8% on a quarter-on-quarter (QoQ) basis. The expenses were down by 1.1% QoQ during the same period.
  • The company's operating profit increased by 0.0% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.0% in 2QFY20 as against 26.8% in 1QFY19.
  • Net profit for the quarter increased by 13.0% QoQ, while net profit margins increased from 10.6% in 1QFY19 to 12.0% in 2QFY20.

To see how TORRENT PHARMA has performed over the last eight quarters,please visit here.

Free Guide: Find the Next Crorepati Stock in this Futuristic Industry

TORRENT PHARMA Share Price Performance

Over the last one year,TORRENT PHARMA share price has moved up from Rs 1,711.5 to Rs 1,798.1, registering a Gain of Rs 86.7 or around 5.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,321.5 (up 0.7%). Over the last one year it has moved down from 14,632.9 to 13,321.5, a gain of 1,311 points (down 9.0%).

Overall, the S&P BSE SENSEX is up 16.5% over the year.

Current Valuations

At the current price of Rs 1,798.1, the price to earnings (P/E) ratio of TORRENT PHARMA stands at 54.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 6.6 times.

Equitymaster requests your view! Post a comment on "TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3%". Click here!

  

Related Views on News

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7% (Quarterly Result Update)

May 22, 2019 | Updated on May 22, 2019

For the quarter ended March 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 166.7% YoY). Sales on the other hand came in at Rs 19 bn (up 7.8% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Dec 13, 2019 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS